VintaBio has put its US$17 million viral vector manufacturing facility up for sale. DSI Assignments has now opened the sale to potential buyers, offering both VintaBio's intellectual property and its 22,500-square-foot production facility in Philadelphia, Pennsylvania.
Business
VintaBio puts US$17M Philadelphia viral vector manufacturing facility up for sale
DSI Assignments has now opened the sale to potential buyers, offering both VintaBio's intellectual property and its 22,500-square-foot production facility in Philadelphia, Pennsylvania.
